Search

Pacira Pharmaceuticals Inc-DE

Закрыт

СекторЗдравоохранение

25.41 2.71

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

24.44

Макс.

25.54

Ключевые показатели

By Trading Economics

Доход

1.7M

4.7M

Продажи

15M

192M

P/E

Средняя по отрасли

71.029

57.366

Прибыль на акцию

0.44

Рентабельность продаж

2.418

Сотрудники

825

EBITDA

-3.9M

26M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+12.81% upside

Дивиденды

By Acuity

Следующий отчет о доходах

5 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-68M

991M

Предыдущая цена открытия

22.7

Предыдущая цена закрытия

25.41

Новостные настроения

By Acuity

51%

49%

293 / 340 Рейтинг в Healthcare

Pacira Pharmaceuticals Inc-DE График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

21 авг. 2026 г., 19:56 UTC

Pacira Biosciences Inc. shares are higher during Friday's session, recovering from a midday dip amid positive sentiment in the broader market.

20 авг. 2026 г., 20:06 UTC

Pacira Biosciences Inc shares are lower today, continuing a decline from Wednesday's close. The stock remains below its 20-day moving average.

19 авг. 2026 г., 19:46 UTC

Pacira Biosciences Inc. shares are higher today, reflecting a broader market trend amid declining bond yields. The stock remains below its 20-day moving average.

18 авг. 2026 г., 20:03 UTC

Shares of Pacira Biosciences are higher, reflecting broader market strength. The stock remains below its 20-day moving average and near the lower end of its trading range.

17 авг. 2026 г., 19:26 UTC

News

Pacira Biosciences Inc shares are higher following Truist Securities' reinstatement of coverage with a Buy rating and a price target of $30.00.

14 авг. 2026 г., 19:36 UTC

Pacira Biosciences Inc shares are lower, marking the seventh consecutive decline. Broader market sentiment is affected by a reported drop in retail sales for July.

13 авг. 2026 г., 20:06 UTC

Pacira Biosciences Inc shares fell during Thursday's session, continuing a trend of declines and remaining below the 20-day moving average. No specific news was identified.

12 авг. 2026 г., 20:01 UTC

Pacira Biosciences Inc's shares are lower today, continuing a downward trend with a cumulative return of -3.36% since Tuesday. No specific news was identified.

11 авг. 2026 г., 19:16 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a trend of three consecutive declines. The stock is trading below its 20-day moving average.

10 авг. 2026 г., 19:36 UTC

Pacira Biosciences Inc is trading lower, continuing a decline since Friday. The stock remains below its 20-day moving average amid broader market volatility.

7 авг. 2026 г., 20:02 UTC

Event

Pacira Biosciences shares are lower despite positive two-year Phase 1 trial results for PCRX-201, an investigational gene therapy for knee osteoarthritis.

6 авг. 2026 г., 19:52 UTC

News
Event

Pacira Biosciences Inc. shares are higher following positive two-year results from its Phase 1 trial for PCRX-201, a gene therapy for knee osteoarthritis.

5 авг. 2026 г., 20:03 UTC

News

Pacira Biosciences reported improved earnings but lowered its 2026 revenue guidance, contributing to a decline in shares since Tuesday's close.

4 авг. 2026 г., 19:53 UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3 авг. 2026 г., 20:06 UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31 июл. 2026 г., 20:02 UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30 июл. 2026 г., 17:16 UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29 июл. 2026 г., 20:04 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28 июл. 2026 г., 19:56 UTC

Event
News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27 июл. 2026 г., 18:51 UTC

Event
News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24 июл. 2026 г., 17:16 UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22 июл. 2026 г., 18:06 UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21 июл. 2026 г., 19:56 UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20 июл. 2026 г., 19:46 UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Сравнение c конкурентами

Изменение цены

Pacira Pharmaceuticals Inc-DE Прогноз

Целевая цена

By TipRanks

12.81% рост

Прогноз на 12 месяцев

Средняя 28.8 USD  12.81%

Максимум 38 USD

Минимум 23 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Pacira Pharmaceuticals Inc-DE на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

6 ratings

3

Покупка

2

Удержание

1

Продажа

Настроения

By Acuity

293 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
help-icon Live chat